(Q73141859)
Statements
Intra-tumoral injection of doxorubicin (adriamycin) encapsulated in liposome inhibits tumor growth, prolongs survival time and is not associated with local or systemic side effects (English)
H Idani
J Matsuoka
T Yasuda
K Kobayashi
1 November 2000